Barclays Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Equalweight

September 8, 2026 2:48 AM

Barclays analyst Yihan Li downgraded Zealand Pharma A/S (ZEAL:DC) (NASDAQ: ZEAL) from Overweight to Equalweight with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found